Tracking cognitive decline in Alzheimer's, disease using the mini-mental state examination: A meta-analysis

International Psychogeriatrics

Volumn 12, Issue 2, 2000, Pages 231-247

  Han, Ling ^a   Cole, Martin ^a,c   Bellavance, Francois ^b   McCusker, Jane ^a   Primeau, Francois ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HEC MONTRÉAL   (Canada)

^c ST MARY S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DISEASE COURSE; HUMAN; NEUROLOGIC EXAMINATION; PATIENT SELECTION; RATING SCALE;

EID: 0033929448     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610200006359     Document Type: Article

References (54)

1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed.-rev.). Washington, DC: Author.
2. Becker, J. T., Bajulaiye, O., & Smith, C. (1992). Longitudinal analysis of a two-component model of the memory deficit in Alzheimer's disease. Psychological Medicine, 22, 437-445.
3. Becker, J. T., Huff, F. J., Nebes, R. D., Holland, A. L., & Boller, F. (1988). Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. Archives of Neurology, 45, 263-268.
4. Burns, A., Jacoby, R., & Levy, R. (1991). Progression of cognitive impairment in Alzheimer's disease. Journal of the American Geriatrics Society, 39, 39-45.
5. Butters, M. A., Lopez, O. L., & Becker, J. T. (1996). Focal temporal lobe dysfunction in probable Alzheimer's disease predicts a slow rate of cognitive decline. Neurology, 46, 687-692.
6. Coen, R. F., Maguire, C., Swanwick, G. R., Kirby, M., Burke, T., et al. (1996). Letter and category fluency in Alzheimer's disease, a prognostic indicator of progression? Dementia, 7, 246-250.
7. Cole, M., & Dastoor, D. (1996). The hierarchic dementia scale, conceptualization. International Psychogeriatrics, 8, 202-212.
8. Cooper, H., & Hedges, L. V. (1994). The handbook of research synthesis. New York: Russell Sage Foundation.
9. Corey-Bloom, J., Galasko, D., Hofstetter, C. R., Jackson, J. E., & Thal, L. J. (1993). Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. Journal of the American Geriatrics Society, 4, 31-37.
10. Drachman, D. A., O'Donnell, B. F., Lew, R. A., & Swearer, J. M. (1990). The prognosis in Alzheimer's disease: 'How far' rather than 'how fast' best predicts the course. Archives of Neurology, 47, 851-856.
11. Dukoff, R., & Sunderland, T. (1997). Durable power of attorney and informed consent with Alzheimer's disease patients, a clinical study. American Journal of Psychiatry, 154, 1070-1075.
12. Ferris, S. H., Mackell, J. A., Mohs, R., Schneider, L. S., Galasko, D., et al. (1997). A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials, overview and general results. Alzheimer Disease and Associated Disorders, 11(Suppl. 2), S1-S12.
13. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
14. Forstl, H., Sattel, H., Besthorn, C., Daniel, S., Geoger-Kabisch, C., et al. (1996). Longitudinal cognitive, electroencephalographic and morphological brain changes in ageing and AD. British Journal of Psychiatry, 168, 280-286.
15. Fritz, C. L., Farver, T. B., Kass, P. H., & Hart, L. A. (1995). Association with companion animals and the expression of noncognitive symptoms in Alzheimer's patients. Journal of Nervous and Mental Disease, 183, 459-463.
16. Galasko, D., Corey-Bloom, J., & Thal, L.J. (1991). Monitoring progression in Alzheimer's disease. Journal of the American Geriatrics Society, 39, 932-941.
17. Galasko, D., Edland, S. D., Morris, J. C., Clark, C., Mohs, R., et al. (1995). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology, 45, 1451-1455.
18. Gallagher-Thompson, D., Brooks, J. O. III, Bliwise, D., Leader, J., & Yesavage, J. A. (1992). The relations among caregiver stress, "sundowning" symptoms, and cognitive decline in Alzheimer's disease. Journal of the American Geriatrics Society, 40, 807-810.
19. Goldblum, M. C., Tzortzis, C., Michot, J. L., Panisset, M., & Boller, F. (1994). Language impairment and rate of cognitive decline in Alzheimer's disease. Dementia, 5, 334-338.
20. Haxby, J. V., Raffael, K., Gillette, J., Schapiro, M. B., & Rapoport, S. I. (1992). Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. Journal of Clinical and Experimental Neuropsychology, 14, 575-592.
21. Holmes, C., Levy, R., McLoughlin, D. M., Powell, J. F., & Lovestone, S. (1996). Apolipoprotein E, non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 61, 580-583.
22. Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., et al. (1994). Age at onset of Alzheimer's disease, relation to pattern of cognitive dysfunction and rate of decline. Neurology, 44, 1215-1220.
23. Kurz, A., Egensperger, R., Haupt, M., Lautenschlager, N., Romero, B., et al. (1996). Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology, 47, 440-443.
24. Kuskowski, M. A., Morley, G. K., Malone, S. M., & Okaya, A. J. (1991). Longitudinal measurements of brainstem auditory evoked potentials in patients with dementia of the Alzheimer type. International Journal of Neuroscience, 60, 79-84.
25. Lopez, O. L., Boller, F., Becker, J. T., Miller, M., & Reynolds, C. F. III. (1990). Alzheimer's disease and depression, neuropsychological impairment and progression of the illness. American Journal of Psychiatry, 147, 855-860.
26. McKhann, G., Drachman, D., Katzman, R., Price, D., & Stadian, E. M. (1984). Clinical diagnosis of Alzheimer's disease, report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939-944.
27. McShane, R., Gedling, K., Reading, M., McDonald, B., Esiri, M. M., et al. (1995). Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 59, 185-188.
28. Miller, T. P., Tinklenberg, J. R., Brooks, J. O. 3d, & Yesavage, J. A. (1991). Cognitive decline in patients with Alzheimer disease, differences in patients with and without extrapyramidal signs. Alzheimer Disease and Associated Disorders, 5, 251-256.
29. Morris, J. C., Edland, S., Clark, C., Galasko, D., Koss, E., et al. (1993). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 2457-2465.
30. Mortimer, J. A., Ebbitt, B., Jun, S. P., & Finch, M. D. (1992). Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology, 42, 1689-1696.
31. Murphy, G. M. Jr., Yang, L., Yesavage, J. A., & Tinklenberg, J. R. (1996). Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant. Neuroscience Letters, 217, 200-202.
32. Obara, K., Meyer, J. S., Mortel, K. F., & Muramatsu, K. (1994). Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type. Journal of the Neurological Sciences, 127, 96-102.
33. Oxman, A. D., Cook, D. J., & Guyatt, G. H. (1994). Users' guides to the medical literature, V. How to use an article about prognosis. Journal of the American Medical Association, 272, 234-237.
34. Pearlson, G. D., Rabins, P. V., Kim, W. S., Speedie, L. J., Moberg, P. J., et al. (1989). Structural brain CT changes and cognitive deficits in elderly depressives with and without reversible dementia ('pseudodementia'). Psychological Medicine, 19, 573-584.
35. Peavy, G. M., Salmon, D. P., Rice, V. A., Galasko, D., Samuel, W., et al. (1996). Neuropsychological assessment of severely demented elderly, the severe cognitive impairment profile. Archives of Neurology, 53, 367-372.
36. Peters, C. A., Potter, J. F., & Scholer, S. G. (1988). Hearing impairment as a predictor of cognitive decline in dementia. Journal of the American Geriatrics Society, 36, 981-986.
37. Pollman, S., Haupt, M., & Kurz, A. (1995). Changes of the relative severity of naming, fluency and recall impairment in the course of dementia of the Alzheimer type. Dementia, 6, 252-257.
38. Rasmusson, D. X. (1996). Predicting rate of cognitive decline in probable Alzheimer's disease. Brain and Cognition, 3, 133-147.
39. Rebok, G., Brandt, J., & Folstein, M. (1990). Longitudinal cognitive decline in patients with Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 3, 91-97.
40. Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., et al. (1995). Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology, 45, 51-55.
41. Salmon, D. P., Thal, L. J., Butter, N., & Heindel, W. C. (1990). Longitudinal evaluation of dementia of the Alzheimer type, a comparison of 3 standardized mental status examinations. Neurology, 40, 1225-1230.
42. SAS. (1997). SAS version 6.12. Cary, NC: Author.
43. Shear, P. K., Sullivan, E. V., Mathalon, D. H., Lim, K. O., Davis, L. F., et al. (1995). A longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. Archives of Neurology, 52, 392-402.
44. Stern, R. G., Mohs, R. C., Bierer, L. M., Silverman, J. M., Schmeidler, J., et al. (1992). Deterioration on the Blessed test in Alzheimer's disease, longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatric Research, 42, 101-110.
45. Taylor, K. I., Salmon, D. P., Rice, V. A., Bondi, M. W., Hill, L. R., et al. (1996). Longitudinal examination of American National Adult Reading Test (AMNART) performance in dementia of the Alzheimer type (DAT), validation and correction based on degree of cognitive decline. Journal of Clinical and Experimental Neuropsychology, 18, 883-891.
46. Teri, L., Hughes, J. P., & Larson, E. B. (1990). Cognitive deterioration in Alzheimer's disease: Behavioral and health factors. Journal of Gerontology. Psychological Sciences, 45, 58-63.
47. Tombaugh, T. N., & McIntyre, N. J. (1992). The Mini-Mental State Examination, a comprehensive review. Journal of the American Geriatrics Society, 40, 922-935.
48. Uhlmann, R. F., Larson, E. B., & Koepsell, T. D. (1986). Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type. Journal of the American Geriatrics Society, 34, 207-210.
49. van Belle, G., Uhlmann, R. F., Hughes, J. P., & Larson, E. B. (1990). Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer's type. Journal of Clinical Epidemiology, 43, 589-595.
50. Wolfe, N., Reed, B. R., Eberling, J. L., & Jagust, W. J. (1995). Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Archives of Neurology, 52, 257-262.
51. World Health Organization. (1992). The international classification of diseases, classification of mental and behavioral disorders (10th ed.). Geneva, Switzerland: Author.
52. Yesavage, J. A., & Brooks, J. O. (1991). On the importance of longitudinal research in Alzheimer's disease. Journal of the American Geriatrics Society, 39, 942-944.
53. Yesavage, J. A., Brooks, J. O. III, Taylor, J., & Tinklenberg, J. (1993). Development of aphasia, apraxia, and agnosia and decline in Alzheimer's disease. American Journal of Psychiatry, 150, 742-747.
54. Yesavage, J. A., Poulsen, S. L., Sheikh, J., & Tanke, E. (1988). Rate of change of common measures of impairment in senile dementia of the Alzheimer's type. Psychopharmacology Bulletin, 24, 531-534.